Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Bao-guang Hu"'
Publikováno v:
BMC Gastroenterology, Vol 20, Iss 1, Pp 1-5 (2020)
Abstract Background Delayed bowel obstruction due to seat belt injury is extremely rare. The delayed onset of nonspecific symptoms makes a timely diagnosis difficult. A deep understanding of the characteristics of this condition is helpful for early
Externí odkaz:
https://doaj.org/article/2993e0c7a96d41e798da84758eed5a24
Autor:
Shan-shan Wang, Lu Feng, Bao-guang Hu, Ying-fei Lu, Wei-mao Wang, Wei Guo, Chun-wai Suen, Bao-hua Jiao, Jian-xin Pang, Wei-ming Fu, Jin-fang Zhang
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 8, Iss , Pp 482-492 (2017)
Recombinant tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), as a novel cancer therapeutic, is being tested in phase II and III clinical trials; however, TRAIL resistance remains a big obstacle preventing its clinical applicatio
Externí odkaz:
https://doaj.org/article/8289b883088d41b494a33c6c1b20a37b
Autor:
Nuozhou Wang, Shanshan Wang, Ming-Yue Li, Bao-guang Hu, Li-ping Liu, Sheng-li Yang, Shucai Yang, Zhongqin Gong, Paul B. S. Lai, George G. Chen
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 10 (2018)
The poor clinical outcome of hepatocellular carcinoma (HCC) patients is ascribed to the resistance of HCC cells to traditional treatments and tumor recurrence after curative therapies. Cancer stem cells (CSCs) have been identified as a small subset o
Externí odkaz:
https://doaj.org/article/65223adeb33448b5b8055b4a0f212b68
Publikováno v:
Case Reports in Gastrointestinal Medicine, Vol 2017 (2017)
Gastric schwannoma (GS) is a rare neoplasm of the stomach. It accounts for 0.2% of all gastric tumors and is mostly benign, slow-growing, and asymptomatic. Due to its rarity, GS is not widely recognized by clinicians, and the precise differential dia
Externí odkaz:
https://doaj.org/article/d5592938370e4a0d978dad1dcde25c5f
Publikováno v:
BMC Gastroenterology, Vol 20, Iss 1, Pp 1-5 (2020)
BMC Gastroenterology
BMC Gastroenterology
Background Delayed bowel obstruction due to seat belt injury is extremely rare. The delayed onset of nonspecific symptoms makes a timely diagnosis difficult. A deep understanding of the characteristics of this condition is helpful for early diagnosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27cf331982b2e70627bd68446997ab5c
http://link.springer.com/article/10.1186/s12876-020-01384-y
http://link.springer.com/article/10.1186/s12876-020-01384-y
Autor:
Juanita L. Merchant, Liping Liu, Shucai Yang, George G. Chen, Shanshan Wang, Zhiyuan Zheng, Charing Cn Chong, Mingyue Li, Nuozhou Wang, Jianwei Ren, Yi Liu, Jianqing Yu, Paul B.S. Lai, Shengli Yang, Bao-guang Hu
Publikováno v:
Cancer Lett
Liver cancer stem cells (LCSCs) initiate hepatocellular carcinoma (HCC) and contribute to its recurrence and treatment resistance. Studies have suggested ZBP-89 as a candidate tumor suppressor in HCC. We explored the role of ZBP-89 in the regulation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b33448943a09ef1c8ffc0be18c88421b
https://doi.org/10.1016/j.canlet.2019.12.026
https://doi.org/10.1016/j.canlet.2019.12.026
Autor:
Shengli Yang, Jianqing Yu, Hao Jia, Jianwei Ren, Paul B.S. Lai, Liping Liu, Bao-guang Hu, George G. Chen, Yi Liu, Zhongqin Gong
Publikováno v:
Oncogenesis
Oncogenesis, Vol 9, Iss 10, Pp 1-11 (2020)
Oncogenesis, Vol 9, Iss 10, Pp 1-11 (2020)
The status of FOXP3 and its isoforms in hepatocellular carcinoma (HCC) is unclear. We aimed to investigate the expression and function of FOXP3 and its isoforms in HCC. The study was performed on 84 HCC patients, HCC cell lines and a mouse tumor mode
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86a2423d9cf0257dd26066ddeea91502
https://doi.org/10.1038/s41389-020-00283-x
https://doi.org/10.1038/s41389-020-00283-x
Autor:
Michael Cf Tong, Jason Y. K. Chan, George G. Chen, Shaoming Zhou, Mo-Xian Chen, Shanshan Wang, Mingyue Li, Shuqi Qiu, Wei Guo, Yi Liu, C. Andrew van Hasselt, Lingbin Xue, Alexander C. Vlantis, Xianhai Zeng, Shucai Yang, Bao-guang Hu
Publikováno v:
Expert opinion on therapeutic targets. 24(9)
Cisplatin is a chemotherapy drug that has been used to treat a number of cancers for decades, and is still one of the most commonly used anti-cancer agents. However, some patients do not respond to cisplatin while other patients who were originally s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16f884d3befe3179389529086980f1b2
https://pubmed.ncbi.nlm.nih.gov/32559147
https://pubmed.ncbi.nlm.nih.gov/32559147
Autor:
Chun-wai Suen, Jinfang Zhang, Jianxin Pang, Wei-Mao Wang, Lu Feng, Bao-hua Jiao, Ying-fei Lu, Shanshan Wang, Wei Guo, Weiming Fu, Bao-guang Hu
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 8, Iss, Pp 482-492 (2017)
Molecular Therapy. Nucleic Acids
Molecular Therapy. Nucleic Acids
Recombinant tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), as a novel cancer therapeutic, is being tested in phase II and III clinical trials; however, TRAIL resistance remains a big obstacle preventing its clinical applicatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::175a18f8d957c93476009139e1fff535
http://www.sciencedirect.com/science/article/pii/S2162253117302263
http://www.sciencedirect.com/science/article/pii/S2162253117302263
Autor:
TIAN-BAO WANG1, BAO-GUANG HU2, DA-WEI LIU33, ZHEN-HUA GAO4 zsdxwtb@163.com, HAN-PING SHI1, WEN-GUANG DONG1
Publikováno v:
Oncology Letters. Aug2016, Vol. 12 Issue 2, p928-932. 5p.